JP2019500056A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019500056A5 JP2019500056A5 JP2018543445A JP2018543445A JP2019500056A5 JP 2019500056 A5 JP2019500056 A5 JP 2019500056A5 JP 2018543445 A JP2018543445 A JP 2018543445A JP 2018543445 A JP2018543445 A JP 2018543445A JP 2019500056 A5 JP2019500056 A5 JP 2019500056A5
- Authority
- JP
- Japan
- Prior art keywords
- fermentation composition
- plant material
- composition according
- algae
- lactic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 17
- 238000000855 fermentation Methods 0.000 claims 15
- 230000004151 fermentation Effects 0.000 claims 15
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims 14
- 241000196324 Embryophyta Species 0.000 claims 9
- 239000000463 material Substances 0.000 claims 9
- 235000014655 lactic acid Nutrition 0.000 claims 7
- 239000004310 lactic acid Substances 0.000 claims 7
- 241000894006 Bacteria Species 0.000 claims 6
- 241001474374 Blennius Species 0.000 claims 6
- 241000195493 Cryptophyta Species 0.000 claims 6
- 241000219198 Brassica Species 0.000 claims 5
- 201000010099 disease Diseases 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 208000011594 Autoinflammatory disease Diseases 0.000 claims 2
- 208000008035 Back Pain Diseases 0.000 claims 2
- 208000035143 Bacterial infection Diseases 0.000 claims 2
- 235000011331 Brassica Nutrition 0.000 claims 2
- 206010010774 Constipation Diseases 0.000 claims 2
- 206010012735 Diarrhoea Diseases 0.000 claims 2
- 244000068988 Glycine max Species 0.000 claims 2
- 235000010469 Glycine max Nutrition 0.000 claims 2
- 244000020551 Helianthus annuus Species 0.000 claims 2
- 235000003222 Helianthus annuus Nutrition 0.000 claims 2
- 206010020751 Hypersensitivity Diseases 0.000 claims 2
- 206010061218 Inflammation Diseases 0.000 claims 2
- 241000124008 Mammalia Species 0.000 claims 2
- 229920003354 Modic® Polymers 0.000 claims 2
- 208000034189 Sclerosis Diseases 0.000 claims 2
- 235000002096 Vicia faba var. equina Nutrition 0.000 claims 2
- 230000004913 activation Effects 0.000 claims 2
- 208000026935 allergic disease Diseases 0.000 claims 2
- 230000007815 allergy Effects 0.000 claims 2
- 208000022362 bacterial infectious disease Diseases 0.000 claims 2
- 239000003638 chemical reducing agent Substances 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 2
- 235000005489 dwarf bean Nutrition 0.000 claims 2
- 244000013123 dwarf bean Species 0.000 claims 2
- 206010016256 fatigue Diseases 0.000 claims 2
- 230000004054 inflammatory process Effects 0.000 claims 2
- 230000007794 irritation Effects 0.000 claims 2
- 230000006641 stabilisation Effects 0.000 claims 2
- 238000011105 stabilization Methods 0.000 claims 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 2
- 241000194033 Enterococcus Species 0.000 claims 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 1
- 241000186660 Lactobacillus Species 0.000 claims 1
- 241000194036 Lactococcus Species 0.000 claims 1
- 206010067125 Liver injury Diseases 0.000 claims 1
- 241000219745 Lupinus Species 0.000 claims 1
- 240000007817 Olea europaea Species 0.000 claims 1
- 241000192001 Pediococcus Species 0.000 claims 1
- 241000199919 Phaeophyceae Species 0.000 claims 1
- 244000046052 Phaseolus vulgaris Species 0.000 claims 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims 1
- 241000206572 Rhodophyta Species 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 239000003529 anticholesteremic agent Substances 0.000 claims 1
- 229940127226 anticholesterol agent Drugs 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 239000013066 combination product Substances 0.000 claims 1
- 229940127555 combination product Drugs 0.000 claims 1
- 230000006806 disease prevention Effects 0.000 claims 1
- 231100000234 hepatic damage Toxicity 0.000 claims 1
- 239000005555 hypertensive agent Substances 0.000 claims 1
- 229940039696 lactobacillus Drugs 0.000 claims 1
- 230000008818 liver damage Effects 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 239000000047 product Substances 0.000 claims 1
- 230000001568 sexual effect Effects 0.000 claims 1
- 208000017520 skin disease Diseases 0.000 claims 1
- 241000894007 species Species 0.000 claims 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA201500700 | 2015-11-08 | ||
| DKPA201500700 | 2015-11-08 | ||
| DKPA201600128 | 2016-02-29 | ||
| DKPA201600128 | 2016-02-29 | ||
| DKPA201600431 | 2016-07-20 | ||
| DKPA201600431 | 2016-07-20 | ||
| DKPA201600537 | 2016-09-14 | ||
| DKPA201600537 | 2016-09-14 | ||
| PCT/EP2016/076952 WO2017077139A1 (en) | 2015-11-08 | 2016-11-08 | Combined pre- and pro-biotic composition |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019500056A JP2019500056A (ja) | 2019-01-10 |
| JP2019500056A5 true JP2019500056A5 (enExample) | 2019-12-19 |
| JP6918007B2 JP6918007B2 (ja) | 2021-08-11 |
Family
ID=57249812
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018543445A Active JP6918007B2 (ja) | 2015-11-08 | 2016-11-08 | 組合せプレバイオティクス及びプロバイオティクス組成物 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20200164009A1 (enExample) |
| EP (1) | EP3370750B1 (enExample) |
| JP (1) | JP6918007B2 (enExample) |
| KR (1) | KR20180080256A (enExample) |
| CN (1) | CN108883143A (enExample) |
| AU (1) | AU2016348786B2 (enExample) |
| BR (1) | BR112018009192B1 (enExample) |
| CA (1) | CA3003775A1 (enExample) |
| ES (1) | ES3045207T3 (enExample) |
| PL (1) | PL3370750T3 (enExample) |
| RU (1) | RU2768499C2 (enExample) |
| WO (1) | WO2017077139A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018103808A1 (en) * | 2016-12-07 | 2018-06-14 | Vivox Aps | A fermented composition comprising a high content of one or more lactic acid bacterial strains and a method for making the composition and use thereof |
| JP2021526385A (ja) * | 2018-04-11 | 2021-10-07 | イッサム リサーチ デベロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム リミテッド | プロバイオティクス細菌で強化された可食性植物部分 |
| WO2020038898A1 (en) * | 2018-08-20 | 2020-02-27 | Fermbiotics Holding ApS | Improved human food product |
| CN109136131A (zh) * | 2018-08-27 | 2019-01-04 | 南昌大学 | 一株具有缓解结肠炎功效的鼠李糖乳杆菌及其应用 |
| US20220023361A1 (en) * | 2018-09-19 | 2022-01-27 | Fermentationexperts A/S | Composition against resistant organisms (mrsa) |
| US20210371886A1 (en) * | 2018-09-19 | 2021-12-02 | Fermentationexperts A/S | Process for controlling a fermentation process |
| TWI693072B (zh) * | 2018-12-14 | 2020-05-11 | 大漢酵素生物科技股份有限公司 | 含有硫苷化合物的抗癌組合物及其用途 |
| KR20220002355A (ko) * | 2019-04-06 | 2022-01-06 | 퍼멘테이션엑스퍼츠 에이/에스 | 항염증성 조성물 |
| TWI766184B (zh) * | 2019-09-04 | 2022-06-01 | 歐斐生 | 一種植物乳桿菌及其製備植物性凝態優格、改善腸道菌相的用途 |
| KR102662148B1 (ko) * | 2020-08-21 | 2024-05-02 | 주식회사 제노포커스 | 프리바이오틱스 또는 신바이오틱스를 유효성분으로 포함하는 면역증강용 조성물 |
| US20240306682A1 (en) * | 2020-11-12 | 2024-09-19 | Fermentationexperts A/S | Process for providing a combination of fermented seaweed and/or algae and plant material selected from the family Fabaceae |
| US11801273B2 (en) | 2020-12-23 | 2023-10-31 | Church & Dwight Co., Inc. | Compositions and methods to increase production of isothiocyanates |
| IT202200013882A1 (it) * | 2022-07-04 | 2024-01-04 | Alfasigma Spa | Prodotto di fermentazione per il trattamento di malattie infiammatorie. |
| KR102881265B1 (ko) * | 2022-11-25 | 2025-11-05 | 국립순천대학교산학협력단 | 다시마 부산물의 발효물을 포함하는 번식기 흑염소용 사료 첨가제 및 그 제조 방법 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0205647D0 (en) * | 2002-03-11 | 2002-04-24 | Danisco Cultor Niebull Gmbh | Method of improving food fermentation procedures |
| FI116878B (fi) * | 2003-02-21 | 2006-03-31 | Maa Ja Elintarviketalouden Tut | Glukosinolaattien entsymaattisen hajottamisen ohjaaminen maitohappobakteerin avulla |
| ES2343576T3 (es) * | 2004-04-15 | 2010-08-04 | Chr. Hansen A/S | Metodo para disminuir el contenido de organismos patogenos presentes en productos alimenticios. |
| JP2006298871A (ja) * | 2005-04-25 | 2006-11-02 | Otaka Koso Kk | 植物エキス発酵液の方法、その方法による植物エキス発酵液並びに哺乳動物の治療方法 |
| JP5626970B2 (ja) * | 2010-07-05 | 2014-11-19 | 株式会社 越後薬草 | ミネラル吸収促進剤 |
| DE102012100466A1 (de) * | 2011-04-21 | 2012-10-25 | Hochschule Fulda | Anlage und Verfahren zur Herstellung eines proteinreichen fettarmen pflanzlichen Produktes aus einem Presskuchen und Verwendung eines proteinreichen fettarmen pflanzlichen Produktes |
| DK177482B1 (en) | 2011-09-02 | 2013-07-08 | Fermentationexperts As | Method of manufacturing a fermented dry feed using a spin flash dryer |
| JP5390589B2 (ja) * | 2011-12-27 | 2014-01-15 | 農業生産法人株式会社 熱帯資源植物研究所 | 血管新生阻害剤 |
| JP5571650B2 (ja) * | 2011-12-27 | 2014-08-13 | 農業生産法人株式会社 熱帯資源植物研究所 | 非アルコール性脂肪性肝疾患および／または非アルコール性脂肪肝炎の治療薬 |
| WO2014131422A2 (en) | 2013-02-28 | 2014-09-04 | Fermentationexperts A/S | Fermented rapeseed feed ingredient |
| CN103190626B (zh) * | 2013-04-17 | 2014-12-03 | 肖天存 | 治疗口腔溃疡的果蔬食品及其制备方法 |
| RS59564B1 (sr) * | 2013-06-28 | 2019-12-31 | Fermentationexperts As | Supstance koje obuhvataju fermentisanu morsku travu i/ili alge |
| CN104543811B (zh) * | 2013-10-21 | 2018-05-15 | 广州博能生物科技有限公司 | 提高免疫力的天然复合粉及其制备方法和应用 |
| CN104273404A (zh) * | 2014-10-10 | 2015-01-14 | 安徽省农业科学院畜牧兽医研究所 | 一种微生物固态发酵菜籽饼粕脱毒的方法 |
-
2016
- 2016-11-08 JP JP2018543445A patent/JP6918007B2/ja active Active
- 2016-11-08 EP EP16791604.8A patent/EP3370750B1/en active Active
- 2016-11-08 BR BR112018009192-8A patent/BR112018009192B1/pt active IP Right Grant
- 2016-11-08 KR KR1020187015036A patent/KR20180080256A/ko not_active Ceased
- 2016-11-08 US US15/774,479 patent/US20200164009A1/en not_active Abandoned
- 2016-11-08 CN CN201680065161.6A patent/CN108883143A/zh active Pending
- 2016-11-08 CA CA3003775A patent/CA3003775A1/en active Pending
- 2016-11-08 ES ES16791604T patent/ES3045207T3/es active Active
- 2016-11-08 RU RU2018121036A patent/RU2768499C2/ru active
- 2016-11-08 AU AU2016348786A patent/AU2016348786B2/en active Active
- 2016-11-08 PL PL16791604.8T patent/PL3370750T3/pl unknown
- 2016-11-08 WO PCT/EP2016/076952 patent/WO2017077139A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019500056A5 (enExample) | ||
| RU2018121036A (ru) | Комбинированная пре- и пробиотическая композиция | |
| US11213552B2 (en) | Method for treating an individual suffering from a chronic infectious disease and cancer | |
| Buford | (Dis) Trust your gut: the gut microbiome in age-related inflammation, health, and disease | |
| US10449222B2 (en) | Method for preventing and/or treating infections, colonisations, or illnesses related to Staphylococcus aureus, Pseudomonas aeruginosa, Streptococcus pyogenes, Enterococcus faecium, Enterobacter cloacae, Proteus mirabilis, Bacteroides fragilis, Staphylococcus epidermidis, Propionibacterium acnes, Candida albicans and/or Malassezia furfur | |
| US20220296655A1 (en) | Method and System for Reducing the Likelihood of Developing Colorectal Cancer in an Individual Human Being | |
| JP2021078504A5 (enExample) | ||
| Brown | Modes of action of probiotics: recent developments | |
| RU2011139211A (ru) | Бактериальные штаммы, обладающие высокой противовоспалительной активностью | |
| JP2019048857A5 (enExample) | ||
| EP4424319A3 (en) | Novel lactobacillus having various functions, and use thereof | |
| JP2018039833A5 (enExample) | ||
| WO2018013583A3 (en) | Medicinal vaginal lactobacillus cocktail | |
| BR112013016690A2 (pt) | agente para induzir a produção de ifn, agente imunopotencializador, agente para prevenção ou tratamento de infecção viral, produto comestível ou bebível, método de triagem de bactérias do ácido lático, microrganismo hospedeiro para uma vacina recombinante | |
| HRP20191440T1 (hr) | Sastavi koji sadrže bakterijske sojeve | |
| NZ745678A (en) | Compositions comprising bacterial blautia strains for treating visceral hypersensitivity | |
| JP2017519730A5 (enExample) | ||
| GB2605271A (en) | Compositions of probiotics and biomass and methods for promoting health in a subject | |
| JP2008538288A5 (enExample) | ||
| Loo et al. | A Current Overview of Next-Generation Probiotics and Their Prospects in Health and Disease Management | |
| Silva et al. | and Other Infectious Diseases: Lactobacillus spp. and Other Potential Bacterial Species | |
| Onyenweaku et al. | Research Article Health Benefits of Probiotics | |
| JP2019156793A5 (enExample) | ||
| BRPI0924418A2 (pt) | composições e métodos para a prevenção e o tratamento de obesidade e síndrome metabólica relacionada à obesidade | |
| RU2016104820A (ru) | Использование пути окислительного стресса у молочнокислых бактерий для поддержания гомеостаза кишечника |